GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » Gross Profit

LifeTech Scientific (HKSE:01302) Gross Profit : HK$1,089 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific Gross Profit?

LifeTech Scientific's gross profit for the six months ended in Dec. 2023 was HK$537 Mil. LifeTech Scientific's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,089 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. LifeTech Scientific's gross profit for the six months ended in Dec. 2023 was HK$537 Mil. LifeTech Scientific's Revenue for the six months ended in Dec. 2023 was HK$687 Mil. Therefore, LifeTech Scientific's Gross Margin % for the quarter that ended in Dec. 2023 was 78.20%.

LifeTech Scientific had a gross margin of 78.20% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of LifeTech Scientific was 81.74%. The lowest was 78.37%. And the median was 80.38%.


LifeTech Scientific Gross Profit Historical Data

The historical data trend for LifeTech Scientific's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Gross Profit Chart

LifeTech Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 595.12 608.30 915.33 975.93 1,089.01

LifeTech Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 456.95 517.61 482.82 552.15 536.86

Competitive Comparison of LifeTech Scientific's Gross Profit

For the Medical Devices subindustry, LifeTech Scientific's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Gross Profit distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's Gross Profit falls into.



LifeTech Scientific Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

LifeTech Scientific's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1386.009 - 297.002
=1,089

LifeTech Scientific's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=686.532 - 149.67
=537

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1,089 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

LifeTech Scientific's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=537 / 686.532
=78.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


LifeTech Scientific  (HKSE:01302) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

LifeTech Scientific had a gross margin of 78.20% for the quarter that ended in Dec. 2023 => Durable competitive advantage


LifeTech Scientific Gross Profit Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific (HKSE:01302) Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
Executives
Xie Yuehui 2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited 2101 Beneficial owner
Hhlr Advisors, Ltd. 2102 Investment manager
Bank Of Communications Trustee Limited 2301 Trustee
Xie Yuehui 2201 Interest of corporation controlled by you
Hhlr Fund, L.p. 2101 Beneficial owner
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines